Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996566281> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W1996566281 endingPage "178" @default.
- W1996566281 startingPage "165" @default.
- W1996566281 abstract "This was a 30-patient Phase II trial of reduced-dose (90)Y ibritumomab tiuxetan (Zevalin) RIT for patients with low-grade, follicular, or transformed B-cell NHL and mild thrombocytopenia. Patients were given an imaging dose of (111)In-labeled ibritumomab tiuxetan for dosimetry measurements. One week later, patients were administered a therapeutic dose of 0.3 mCi/kg (11 MBq/kg) (90)Y ibritumomab tiuxetan. Both (111)In- and (90)Y-labeled ibritumomab tiuxetan doses were preceded by an infusion of 250 mg/m(2) rituximab (Rituxan, MabThera) an unlabeled chimeric anti-CD20 antibody, to clear peripheral blood B cells and improve biodistribution of the radiolabeled antibody. For all 30 patients, normal organ and red marrow radiation absorbed doses were well below protocol-defined limits of 2000 cGy and 300 cGy, respectively. Median radiation absorbed doses were 48 cGy to red marrow (range: 6.5-95 cGy), 393 cGy to liver (range: 92-1581 cGy), 522 cGy to spleen (range: 165-1711 cGy), 162 cGy to lungs (41-295 cGy), and 14 cGy to kidneys (0.03-65 cGy). Though most correlative analyses were negative, certain analyses demonstrated a statistically significant correlation between the severity or duration of thrombocytopenia and pharmacokinetic or dosimetric parameters. These correlations were not consistent across the total patient population, and therefore, could not be exploited to predict hematologic toxicity." @default.
- W1996566281 created "2016-06-24" @default.
- W1996566281 creator A5004152557 @default.
- W1996566281 creator A5008846063 @default.
- W1996566281 creator A5016917647 @default.
- W1996566281 creator A5017603782 @default.
- W1996566281 creator A5019803931 @default.
- W1996566281 creator A5027013288 @default.
- W1996566281 creator A5069302126 @default.
- W1996566281 creator A5070797442 @default.
- W1996566281 creator A5078397650 @default.
- W1996566281 creator A5086132292 @default.
- W1996566281 creator A5090641314 @default.
- W1996566281 date "2003-04-01" @default.
- W1996566281 modified "2023-09-26" @default.
- W1996566281 title "Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia" @default.
- W1996566281 cites W1561191726 @default.
- W1996566281 cites W1892026381 @default.
- W1996566281 cites W1992341639 @default.
- W1996566281 cites W2054823183 @default.
- W1996566281 cites W2068079045 @default.
- W1996566281 cites W2080416356 @default.
- W1996566281 cites W2107466475 @default.
- W1996566281 cites W2149156161 @default.
- W1996566281 cites W2267583049 @default.
- W1996566281 doi "https://doi.org/10.1089/108497803765036337" @default.
- W1996566281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12804042" @default.
- W1996566281 hasPublicationYear "2003" @default.
- W1996566281 type Work @default.
- W1996566281 sameAs 1996566281 @default.
- W1996566281 citedByCount "30" @default.
- W1996566281 countsByYear W19965662812012 @default.
- W1996566281 countsByYear W19965662812013 @default.
- W1996566281 countsByYear W19965662812014 @default.
- W1996566281 countsByYear W19965662812016 @default.
- W1996566281 crossrefType "journal-article" @default.
- W1996566281 hasAuthorship W1996566281A5004152557 @default.
- W1996566281 hasAuthorship W1996566281A5008846063 @default.
- W1996566281 hasAuthorship W1996566281A5016917647 @default.
- W1996566281 hasAuthorship W1996566281A5017603782 @default.
- W1996566281 hasAuthorship W1996566281A5019803931 @default.
- W1996566281 hasAuthorship W1996566281A5027013288 @default.
- W1996566281 hasAuthorship W1996566281A5069302126 @default.
- W1996566281 hasAuthorship W1996566281A5070797442 @default.
- W1996566281 hasAuthorship W1996566281A5078397650 @default.
- W1996566281 hasAuthorship W1996566281A5086132292 @default.
- W1996566281 hasAuthorship W1996566281A5090641314 @default.
- W1996566281 hasConcept C126322002 @default.
- W1996566281 hasConcept C159654299 @default.
- W1996566281 hasConcept C203014093 @default.
- W1996566281 hasConcept C2776146153 @default.
- W1996566281 hasConcept C2778515704 @default.
- W1996566281 hasConcept C2779338263 @default.
- W1996566281 hasConcept C2908647359 @default.
- W1996566281 hasConcept C2989005 @default.
- W1996566281 hasConcept C542903549 @default.
- W1996566281 hasConcept C71924100 @default.
- W1996566281 hasConcept C75088862 @default.
- W1996566281 hasConcept C99454951 @default.
- W1996566281 hasConceptScore W1996566281C126322002 @default.
- W1996566281 hasConceptScore W1996566281C159654299 @default.
- W1996566281 hasConceptScore W1996566281C203014093 @default.
- W1996566281 hasConceptScore W1996566281C2776146153 @default.
- W1996566281 hasConceptScore W1996566281C2778515704 @default.
- W1996566281 hasConceptScore W1996566281C2779338263 @default.
- W1996566281 hasConceptScore W1996566281C2908647359 @default.
- W1996566281 hasConceptScore W1996566281C2989005 @default.
- W1996566281 hasConceptScore W1996566281C542903549 @default.
- W1996566281 hasConceptScore W1996566281C71924100 @default.
- W1996566281 hasConceptScore W1996566281C75088862 @default.
- W1996566281 hasConceptScore W1996566281C99454951 @default.
- W1996566281 hasIssue "2" @default.
- W1996566281 hasLocation W19965662811 @default.
- W1996566281 hasLocation W19965662812 @default.
- W1996566281 hasOpenAccess W1996566281 @default.
- W1996566281 hasPrimaryLocation W19965662811 @default.
- W1996566281 hasRelatedWork W1965667364 @default.
- W1996566281 hasRelatedWork W1970641137 @default.
- W1996566281 hasRelatedWork W1992057529 @default.
- W1996566281 hasRelatedWork W1995516730 @default.
- W1996566281 hasRelatedWork W1996566281 @default.
- W1996566281 hasRelatedWork W2056601883 @default.
- W1996566281 hasRelatedWork W2080416356 @default.
- W1996566281 hasRelatedWork W2087631306 @default.
- W1996566281 hasRelatedWork W2121615960 @default.
- W1996566281 hasRelatedWork W2158284291 @default.
- W1996566281 hasVolume "18" @default.
- W1996566281 isParatext "false" @default.
- W1996566281 isRetracted "false" @default.
- W1996566281 magId "1996566281" @default.
- W1996566281 workType "article" @default.